VIVACELLE BIO, Inc. is a developmental stage biotechnology company focused on creating products that utilize nanoparticle technology. The Company's first product, VBI-1, is a colloid non-blood volume expander that appears to be two to three times more effective than the standard treatment for hypovolemia and safer in animal studies/experiments. On February 1, 2019, the FDA granted clearance to initiate our phase IIa clinical trial using VBI-1. VBI-1, is primarily-designed to treat hypovolemia due to hemorrhagic shock (blood loss).The company is also developing a second product, VBI-S, to treat hypovolemia due to sepsis/septic shock. This new class of resuscitation fluids is named, VIVACELLE.
VIVACELLE restores blood pressure, circulating volume and there by increases survival in animal models of hypovolemia. Hypovolemia, which occurs when there is inadequate fluid volume in the blood vessels, causes the death of over a one million people globally each year. Causes include acute blood loss from trauma, surgery, shock, sepsis, severe diarrhea and burns. When the circulating volume is inadequate to maintain tissue perfusion and oxygenation, cellular injury and death may result.
Rapid volume replacement and re-establishment of normal blood pressure are essential to survival. Unfortunately, the current fluid treatments for hypovolemia, such as non-blood volume expanders (colloids and crystalloids), blood products and blood substitutes have proven impractical and have the potential for significant negative adverse effects. VBI-1, a suspension of lipid droplets which form nanoparticles represents a new paradigm for use in fluid resuscitation, safely restoring blood vessel volume and reversing the effects of hypovolemia. In addition, VBI-1 has several promising properties that may address other detrimental events contributing to cell death:
Sign up to hear from us about specials, sales, and events.
Vivacelle Bio, Inc.
Northeast Indiana Innovation Center,
3201 Stellhorn Road
Suite 129 A
Fort Wayne, IN 46815
Vivacelle Bio Inc., The Bunker Labs
1555 Sherman Ave., Box 326 Evanston,
Illinois 60201
Physical Addresses:
Vivacelle Bio, Inc.
Northeast Indiana Innovation Center,
3201 Stellhorn Road
Suite 129 A
Fort Wayne, IN 46815
Vivacelle Bio, Inc., The Bunker Labs
125 S. Clark St., We Work, 17th Floor,
Chicago, Illinois 60603
3201 Stellhorn Rd, Fort Wayne, Indiana 46835, United States
Mon | 09:00 am – 05:00 pm | |
Tue | 09:00 am – 05:00 pm | |
Wed | 09:00 am – 05:00 pm | |
Thu | 09:00 am – 05:00 pm | |
Fri | 09:00 am – 05:00 pm | |
Sat | Closed | |
Sun | Closed |
Copyright © 2020 Vivacelle Bio Inc. - All Rights Reserved.
Powered by GoDaddy Website Builder